B8a Missed Opportunities for Chlamydia Trachomatis (CT) Retesting and Implications for Structural Interventions at the Clinic Level: Differences in Retesting Rates by Type of Return Visit within the California Family Planning (FP) Setting

Tuesday, March 9, 2010: 3:15 PM
Dogwood A (M1) (Omni Hotel)
Holly Howard, MPH1, Joan Chow, DrPH1, Heidi Bauer, MD, MS, MPH2, Glenn Wright, MPA1, Mary Menz, RN, PHN3, Regina Zerne, MS4 and Gail Bolan, MD5, 1STD Control Branch, California Department of Public Health, Richmond, CA, 2Sexually Transmitted Disease (STD) Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, 3Family Planning, Access, Care, and Treatment (PACT) Program Support and Evaluation, Bixby Center for Global Reproductive Health, Sacramento, CA, 4Family PACT Progam, Office of Family Planning, California Department of Public Health, Sacramento, CA, 5STD Control Branch, California Department of Public Health, STD Control Branch, Richmond, CA

Background:  CT reinfection is common and associated with adverse reproductive complications, yet retesting rates remain low in FP settings. 

Objectives: To describe clinic return and retesting patterns by visit type among female CT cases in California FP settings to inform structural interventions for improved opportunistic retesting.

Methods: Using 2007 Quest laboratory data and Family PACT claims, we determined the proportion of a CT-positive female cohort returning for services and retested 2-6 months post-diagnosis.  Return and retesting rates were stratified by visit type categories defined hierarchically using diagnostic codes and clinic, laboratory, and pharmacy claims.

Results: Overall, 82,186 female Family PACT clients were tested for CT by Quest in 2007; 3.2% (n=2,594) tested positive.  Forty-nine percent of cases returned for services 2-6 months post-diagnosis, and, of these, 50% were retested at their first return visit, giving an overall 25% retesting rate.  The reinfection rate was 15%.  Of 1,267 first-return visits, 26% were symptom-related, 23% birth control (BC) consults without pelvic exam, 10% limited-service pregnancy testing (PT) or emergency contraception (EC), 9% Pap smears, 9% STD-testing-only, 6% limited-service BC refills, 5% extended-services for PT, 3% abnormal Pap follow-up, and 11% could not be categorized.  Retesting rates varied significantly by return visit type, with lowest rates among abnormal Pap follow-ups (12%), limited-service BC refills (22%), and limited-service PT or EC (23%).  Retesting rates were highest among visits for STD-testing-only (96%), Pap smears (86%), and symptoms (69%).   

Conclusions: Although nearly half of female CT cases in California FP settings return for services during the recommended retesting period, CT retesting is missed at 50% of first visits.  Limited-service visits are least likely to trigger retesting by providers.

Implications for Programs, Policy, and/or Research: Simple structural interventions (e.g., chart prompts and trigger questions on history/exam forms) could improve opportunistic retesting regardless of reason for visit.  Improving opportunistic retesting may detect reinfections earlier and reduce adverse reproductive consequences.

Previous Abstract | Next Abstract >>